Latest filing published 15 Mar 2016 for Eledon Pharmaceuticals, Inc., €41k.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -85.0%Entry US$902.34 · Close at T+365 US$135.43
- -17.3%Entry US$35.55 · Close at T+365 US$29.40
- +3.5%Entry US$39.90 · Close at T+365 US$41.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen Buckley Jr.: trading record in brief
This profile gathers the share dealings of Stephen Buckley Jr. across 2 companies, led by Enanta Pharmaceuticals Inc and Eledon Pharmaceuticals, Inc. In total, 5 filings cover trades dated from 14 August 2014 to 15 March 2016.
The open-market record is one-sided, with 5 purchases worth €132k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2016 alone, the filings show 1 purchase and no sales.
The median purchase comes to €29k. Ninety days after publication, 4 purchases show a median change of +12.8%, with the price up in 100% of them. These figures describe past trades and do not predict future prices.
On 15 March 2016 came the latest disclosure, an open-market purchase for €41k in Eledon Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephen Buckley Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares@ US$5.74100.0% of flowCommon StockSEC:0001562180-16-001972:0Canonical exit: 13 Jun 2016 (T+90)
- 3,000 shares@ US$11.25Common StockSEC:0001562180-15-000971:0Canonical exit: 9 Feb 2016 (T+90)
- 400 shares@ US$33.69Common StockSEC:0000908662-15-000066:0Canonical exit: 19 May 2015 (T+90)
- 600 shares@ US$34.20Common StockSEC:0000908662-15-000066:1Canonical exit: 20 May 2015 (T+90)
- 1,000 shares@ US$38.95Common StockSEC:0000908662-14-000244:0Canonical exit: 12 Nov 2014 (T+90)
5 of 5 declarations